Advantage Alpha Capital Partners LP Cuts Stock Holdings in Trupanion, Inc. (NASDAQ:TRUP)

Advantage Alpha Capital Partners LP reduced its position in shares of Trupanion, Inc. (NASDAQ:TRUP) by 8.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 57,957 shares of the financial services provider’s stock after selling 5,542 shares during the quarter. Advantage Alpha Capital Partners LP’s holdings in Trupanion were worth $2,794,000 as of its most recent SEC filing.

Other institutional investors have also recently modified their holdings of the company. FMR LLC increased its holdings in Trupanion by 55,963.7% in the 3rd quarter. FMR LLC now owns 1,172,293 shares of the financial services provider’s stock worth $49,213,000 after acquiring an additional 1,170,202 shares in the last quarter. Amundi lifted its holdings in Trupanion by 193.2% in the 4th quarter. Amundi now owns 16,828 shares of the financial services provider’s stock valued at $784,000 after purchasing an additional 11,088 shares in the last quarter. Barclays PLC boosted its stake in Trupanion by 259.2% during the 3rd quarter. Barclays PLC now owns 65,498 shares of the financial services provider’s stock worth $2,750,000 after purchasing an additional 47,262 shares during the last quarter. Wealthfront Advisers LLC purchased a new stake in shares of Trupanion during the fourth quarter worth $845,000. Finally, Proficio Capital Partners LLC acquired a new stake in shares of Trupanion in the fourth quarter valued at about $976,000.

Trupanion Price Performance

TRUP opened at $37.00 on Monday. The firm has a market cap of $1.57 billion, a price-to-earnings ratio of -160.87, a PEG ratio of 6.02 and a beta of 1.70. The company has a current ratio of 1.71, a quick ratio of 1.66 and a debt-to-equity ratio of 0.39. The stock’s 50-day moving average price is $41.64 and its 200 day moving average price is $46.74. Trupanion, Inc. has a 12-month low of $19.69 and a 12-month high of $57.90.

Trupanion (NASDAQ:TRUP) last posted its quarterly earnings data on Wednesday, February 19th. The financial services provider reported $0.04 EPS for the quarter, missing the consensus estimate of $0.06 by ($0.02). The business had revenue of $337.31 million during the quarter, compared to analysts’ expectations of $335.41 million. Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. As a group, sell-side analysts expect that Trupanion, Inc. will post 0.13 earnings per share for the current year.

Insiders Place Their Bets

In other Trupanion news, insider Brenna Mcgibney sold 5,000 shares of the business’s stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $32.99, for a total transaction of $164,950.00. Following the completion of the transaction, the insider now owns 3,738 shares in the company, valued at $123,316.62. The trade was a 57.22 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Margaret Tooth sold 2,294 shares of Trupanion stock in a transaction on Tuesday, March 4th. The stock was sold at an average price of $31.39, for a total transaction of $72,008.66. Following the sale, the chief executive officer now directly owns 118,784 shares of the company’s stock, valued at approximately $3,728,629.76. This trade represents a 1.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 25,984 shares of company stock worth $850,362 in the last quarter. 5.50% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on the company. Stifel Nicolaus reduced their price target on Trupanion from $44.00 to $41.00 and set a “hold” rating on the stock in a report on Thursday, February 20th. Piper Sandler decreased their price objective on Trupanion from $57.00 to $52.00 and set an “overweight” rating on the stock in a report on Thursday, February 20th. Two equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, Trupanion presently has an average rating of “Moderate Buy” and an average target price of $46.60.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.